TARA REILLY: Open Payments
NPI 1710905104 · SAN FRANCISCO, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$728 in 31 payments from 11 companies in 2025. Trend: 2023 $484 · 2024 $857 · 2025 $728
Food & beverage: $728
| Company | Payments | Amount |
|---|---|---|
| ViiV Healthcare Company | 6 | $152 |
| Astellas Pharma US Inc | 6 | $148 |
| ABBVIE INC. | 4 | $95 |
| Lilly USA, LLC | 4 | $85 |
| Novo Nordisk Inc | 3 | $65 |
| Exact Sciences Corporation | 2 | $53 |
| PFIZER INC. | 2 | $37 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $33 |
| GlaxoSmithKline, LLC. | 1 | $26 |
| Napo Pharmaceuticals Inc | 1 | $18 |
Products named: Veozah, APRETUDE, MOUNJARO, QULIPTA, RUKOBIA, PREVNAR 20, The Cologuard Plus Collection Kit, SHINGRIX.
Industry payments across CA — which companies pay providers there.
